PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

PAR -v- CUV, page-68

  1. 4,351 Posts.
    lightbulb Created with Sketch. 6891
    MrSnapple, thanks for the update, I saw that CUV went into Trading Halt but assumed we wouldn't hear the FDA verdict till later this week.
    Great news, I only have a very small exposure to CUV but its good for fellow shareholders and of course has indirect ramifications as you mentioned to PAR.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.